DE version is available. Content is displayed in original English for accuracy.
Advertisement
Advertisement
⚡ Community Insights
Discussion Sentiment
68% Positive
Analyzed from 2034 words in the discussion.
Trending Topics
#cancer#mrna#keytruda#group#https#week#vaccine#moderna#vaccines#news
Discussion (117 Comments)Read Original on HackerNews
We never wore sunscreen as kids because we didn't burn. I probably have had three sunburns in my life. Learned once I became an adult that that wasn't sound logic...
https://www.merck.com/news/merck-and-moderna-announce-phase-...
Still no actual Phase 3 data presented.
So this should answer the question of "how much better is this with the best we currently have".
https://archive.ph/SQQ97
I wish this treatment was available a few years ago.
Related stories:
https://www.fiercebiotech.com/biotech/merck-and-modernas-per...
https://www.reuters.com/legal/litigation/merck-moderna-say-m...
https://www.wsj.com/health/pharma/moderna-merck-vaccine-succ...
Here's a great blog post on this, "How to build a cancer vaccine, and whether they will work this time": https://www.owlposting.com/p/how-to-build-a-cancer-vaccine-a...
Here's the blog post I wrote on personalized mRNA vaccines: https://hedonicescalator.substack.com/p/did-paul-conyngham-r...
Moderna used a simple heuristic, "how likely is this antigen to show up on the cell surface?" which makes sense, since an antigen has to show up on the cell surface for the immune system to see it. But there's so much missing from this model, and we just don't have enough data. Failures in clinical trials of mRNA vaccines may well be caused by this problem. (Yes, this is a good problem for AI, if we can get enough data).
"Almost never" is doing a lot of work. You may be aware that most drugs fail over the course of development and human trials?
Anyway, checkpoint inhibitor therapy is a massive boon to oncology and was only brought into widespread use over the past 15 years.
Those few exceptions have been monumental in how they've changed cancer treatment. Skin cancer has been particularly well treated with immunotherapy, but other cancers have also benefited from the exact same research and drugs (as it turns out, the specific mutations the immunotherapies like Keytruda target express in other cancers). The reason skin cancer gets so much attention is because it's one of the most commonly diagnosed and treated cancers. (Colon is more common, I believe, but it often doesn't get detected. Get your colonoscopies folks).
It has moved fast enough that I've heard from multiple oncologists that the all 5 year survivability numbers are dated because the treatments are newer than the studies.
We've come a LONG way in a very short period in terms of cancer treatment. It still sucks, but not as much as it once did.
Biotech is one of the very very very few areas of the stockmarket where specialist knowledge generates alpha.
Trolling through random biotechs, learning about their tech, and investing in the most promising applications of that tech in the most impactful areas is something that happens somewhat on publicly traded markets. With tech, most of that happens pre-IPO.
I'm very very excited to see what comes next.
I feel like everything companies, and presidents, say now is directly geared to triggering AI trades.
The only thing they are looking at with this drug is people living one more month over existing drugs.
THIS IS NOTHING.
"The median PFS (progression-free survival) for KEYTRUDA was 5.5 months (2-week group) and 4.1 months (3-week group) compared to 2.8 months for ipilimumab (HR 0.58, P<0.00001 for the KEYTRUDA groups vs. ipilimumab,"
https://www.merck.com/news/keytruda-pembrolizumab-mercks-ant...
The median PFS (progression-free survival) for KEYTRUDA was 5.5 months (2-week group) and 4.1 months (3-week group) compared to 2.8 months for ipilimumab (HR 0.58, P<0.00001 for the KEYTRUDA groups vs. ipilimumab, 95% CI, 0.46-0.72 for 2-week group and 0.47-0.72 for 3-week group, respectively). The estimated 6-month PFS rates for the KEYTRUDA and ipilimumab arms were 47.3 percent, 46.4 percent and 26.5 percent, respectively. One-year OS for KEYTRUDA was 74.1 percent (2-week group) and 68.4 percent (3-week group) compared to 58.2 percent for ipilimumab (HR 0.63 [95% CI, 0.47-0.83, P=0.00052] for the 2-week group and HR 0.69 [95% CI, 0.52-0.90, P=0.00358] for the 3-week group). At the time of analysis, median overall survival was not reached in any treatment group.
2. I don't think AI was mentioned once in this press release.
3. This drug was approved for trial in 2014, so if it had something to do with deep learning, that would actually be a massive announcement.
4. The paragraph immediately following the one you clipped talks about Overall Response Rate (ORR) and throughout the release they discuss Overall Survival (OS).
5. This is not "NOTHING" in statistical terms, but even more so to people with melanoma.
Can you clarify that? It saved 100K+ lives even by incredibly conservative estimates, and allowed life to returned to normal at least a year earlier than otherwise.
Did we enter a new era or where you not paying attention or affecting you before?
Reminds me of the old adage of:
Q: "Why is no one speaking about this?"
R: "Is no one talking about this, or are you just 20 and its the first time you are hearing about it?"
However, that discussion was largely side-tracked by the massive amount of disinformation (eg, "Plandemic") that circulated online. There are people who to this day swear that COVID-19 was just like the flu and simultaneously claim that the vaccine spike proteins have killed around 20M people. Not just crackpots, but people with reach, like Brett Weinstein on Joe Rogan's podcast.
But we have already protocols and frameworks on public health.
Also plenty of other medical choices are taken with way less input of experts (see abortion discussions for example)
Not sure, the midst of a global crisis, with almost universal scientific approval is the time to have a long discussion on bodily autonomy on countries like america where 50% of people cant read at a 6th grade level.
There is a legitimate discussion (dating back at least to Typhoid Mary (1) ) on excluding people from public spaces when they refuse to take basic public health measures. Taking a vaccine for a spreading deadly pandemic is one of those measures.
Doing something so violently anti-social is not simply a "bodily autonomy" issue, and framing it only as such is deeply misguided in a way that seems particular to some USA norms.
1) https://en.wikipedia.org/wiki/Mary_Mallon
> In 1907, she was forcibly quarantined at the Riverside Hospital
A bunch of grifters pushed fear, uncertainty, and doubt for personal gain, at the expense of the health of the nation. I try not to blame people who got tricked, but at some point we need to treat people like adults who are responsible for their own actions, and hold them accountable for the harm they perpetuate by believing BS and acting on it.
A democracy cannot function when its members are low-functioning, and when bad information dominates. Those who spread disinformation, relish the conspiracy and disinformation because it makes them feel special emotionally, and wallow in the mess of it, are hurting us all.